Prevalence of ocular surface disease in patients with glaucoma on topical medications

  • Vijaya Pai Department of Ophthalmology, Kasturba Medical College, Manipal University, Manipal, India
  • L Satya Hareesh Reddy Department of Ophthalmology, Kasturba Medical College, Manipal University, Manipal, India
DOI: https://doi.org/10.35119/asjoo.v16i2.382
Keywords: antiglaucoma medications, dry eye, ocular surface disease index (OSDI), preservatives

Abstract

Aim: To compare the prevalence of ocular surface disease (OSD) in patients using antiglaucoma medications vs normal subjects.

Design: Prospective observational study.

Methods: A total of 94 patients with glaucoma on topical medications were included in the study group. Age- and gender-matched normal subjects (n = 94) formed the control group. They were assessed for OSD using ocular surface disease index (OSDI) questionnaire, tear break-up time (TBUT), Lissamine green staining, and Schirmer’s test.

Results: The prevalence of OSD was significantly more in the study group (72.4%) when compared to controls (44.6%) using the OSDI questionnaire. Schirmer’s test showed 84% patients had decreased tear production in the study group vs 53% in controls. TBUT was abnormal in 67.1% of the study group and of 47.8% controls. Lissamine green staining was positive in 36.2% of patients in the study group and 31.8% of controls.

Conclusion: OSD was more common in patients using intraocular pressure (IOP)-lowering drugs than in controls. Long-term therapy and multiple medications were associated with severe OSD.

Author Biography

Vijaya Pai, Department of Ophthalmology, Kasturba Medical College, Manipal University, Manipal, India
Professor, Department of Ophthalmology

References

1. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J
Glaucoma. 2008;17(5):350-355.
2. Baudouin C. Detrimental effect of preservatives in eye drops: implications for the treatment of
glaucoma. Acta Ophthalmol. 2008;86(7):716-726.
3. European Glaucoma Society, Terminology and guidelines for glaucoma. In: European Glaucoma
Society Guidelines. 3rd ed. Savona, Italy: Editrice Dogma; 2008;117-153.
4. Baudouin C, Labbé A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eye drops: the
good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312-334.
5. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the
ocular surface disease index. Arch Ophthalmol. 2000;118(5):615-621.
6. Lemp MA, Foulks GN. The definition and classification of dry eye disease. The Ocular Surface.
2007;5(2):75-92.
7. Schein OD, Muño B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the
elderly. Am J Ophthalmol. 1997;124(6):723-728.
8. Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular
surface complaints in patients with glaucoma using topical intraocular pressure-lowering
medications. Cornea. 2010; 29(6):618-621.
9. Baudouin C. The ocular surface in glaucoma. Cornea. 2009;28(11):S14-9.
10. Barisic F, Krolo I, Popovic- Suic S, et al. Prevalence of ocular surface disease in patients with
glaucoma using topical antiglaucoma medications. J Clin Exp Ophthalmol. 2014;5:334.
11. Niveditha H, Vinutha BV, Himamshu NV, et al. Prevalence of ocular surface disease in glaucoma
patients using anti-glaucoma medications. Journal of Evolution of Medical and Dental Sciences.
2013;2(23):4308-4314.
12. Garcia-Feijoo J, Sampaolesi JR. A multicenter evaluation of ocular surface disease prevalence in
patients with glaucoma. Clin Ophthalmol. 2012;6:441-446.
Published
2018-11-21
How to Cite
Pai, V., & Reddy, L. S. H. (2018). Prevalence of ocular surface disease in patients with glaucoma on topical medications. Asian Journal of Ophthalmology, 16(2), 101-109. https://doi.org/10.35119/asjoo.v16i2.382
Issue
Vol 16 No 2 (2018): Asian Journal of Ophthalmology
Section
Original Articles

Copyright (c) 2018 Asian Journal of Ophthalmology

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication, with the work twelve (12) months after publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).